{
  "id": 11574304,
  "title": "DocuSign chief legal officer Shaughnessy sells $825,552 in shares",
  "url": "https://urgent.news/2026/10/03/docusign-chief-legal-officer-shaughnessy-sells-825-552-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-03T01:30:55.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/docusign-chief-legal-officer-shaughnessy-sells-825552-in-shares-93CH-4930648"
  },
  "original_language": "en",
  "account": "DocuSign's Chief Legal Officer, James P. Shaughnessy, recently sold 12,000 shares of the company's common stock, totaling $825,552. The sales were made in accordance with a pre-established Rule 10b5-1 trading plan and took place in two batches. The first batch saw Shaughnessy offloading 11,600 shares, averaging $68.77 per share. The price per share fluctuated between $68.30 and $69.23 for this portion of the sale. A second batch consisted of 400 shares, which were sold at an average price of $69.55 per share, with the price for these shares ranging from $69.39 to $69.68. Despite these reported sales, Mr. Shaughnessy still owns 50,591 shares of DocuSign directly. This insider sale coincides with DocuSign's stock experiencing a 43% increase over the past six months, currently trading at $69.01. Analyzing the stock, InvestingPro suggests it is undervalued based on its Fair Value assessment. DocuSign boasts a robust financial health score, bolstered by gross profit margins nearing 80%. Additionally, the company has reported robust second-quarter results, with revenue growth accelerating to 9.4%, fueled by increased digital sales and advancements in their Identity and Access Management (IAM) services. This performance has prompted several analysts to revise their price targets and ratings positively. Notably, Citi raised its price target to $72, Baird increased theirs to $72, and Morgan Stanley raised theirs to $75, all citing positive trends in Docusign's annual recurring revenue growth. Morgan Stanley took it a step further by raising its price target to $75. Needham, however, maintained a Hold rating, acknowledging Docusign's strong performance. Wells Fargo, on the other hand, lowered its price target to $60, noting the company's approximately 8% revenue growth in constant currency. These adjustments in analyst ratings and price targets underscore the market's recognition of Docusign's recent financial achievements and strategic advancements.",
  "summary": null,
  "key_points": [
    "Shaughnessy sold 12,000 shares of DocuSign, totaling $825,552",
    "Sales made in two batches, first 11,600 shares at $68.77 avg",
    "DocuSign stock up 43% over six months, currently $69.01"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}